Ativan (Lorazepam) Withdrawal: Symptoms, Seizure Risk, and How a Taper Works

What is Ativan withdrawal?

It is what happens when a body that has adapted to lorazepam loses it too fast. The Ativan label carries a boxed warning: continued use can lead to clinically significant physical dependence, and abrupt discontinuation or rapid dose reduction can bring acute withdrawal reactions that can be life-threatening. The risk rises with a longer course and a higher daily dose. The label’s instruction is short: use a gradual taper to stop Ativan or lower the dose.

Dependence is not addiction. The Medication Guide says so in plain words, and a person can be physically dependent on lorazepam taken exactly as prescribed. That matters for two groups of readers. Someone who has taken Ativan nightly for a year for anxiety may need a taper even though nothing about their use was wrong. Someone buying pills sold as Ativan has a second problem, covered below.

If you are comparing Ativan with Librium or Valium, for alcohol detox or for a taper, our Librium vs Ativan vs Valium guide has the side-by-side table. This page is about coming off lorazepam.

Ativan withdrawal symptoms

The label lists acute withdrawal signs that range from uncomfortable to dangerous:

One practical problem: withdrawal brings anxiety and insomnia, which may be what the medicine was prescribed for in the first place. The label warns that this can make it hard to tell withdrawal from the original symptoms coming back. That is one more reason to taper with the prescriber who knows the history.

How long does Ativan withdrawal last?

No source we found gives a reliable day-by-day calendar for lorazepam withdrawal, so treat any chart that does with suspicion. What the sources do say:

• The label puts the mean half-life of lorazepam at about 12 hours, with peak blood levels about 2 hours after a dose.
• The 2025 joint tapering guideline says lorazepam has no active metabolites.
• The same guideline links more severe withdrawal to benzodiazepines with a shorter half-life and fewer active metabolites, along with daily use, higher doses, longer use, and past severe withdrawal. It gives Xanax (alprazolam) as an example.
• The protracted phase, when it happens, can run from weeks to more than a year, per the label.

The guideline does not single out Ativan, but lorazepam shares both features: a half-life far shorter than Valium’s or Librium’s and no active metabolites. And at the guideline’s pace, a taper for someone who has taken it daily for months is measured in months, not days.

Who is at risk of withdrawal?

The 2025 guideline gives a rule of thumb based on how long, how often and how much. Its dose bands use lorazepam as one of its examples:

The guideline calls this general guidance that does not replace clinical judgment, and says age, other health conditions, other substance use and past withdrawal all change the risk. For scale: the label’s usual Ativan range is 2 to 6 mg a day in divided doses, with a range of 1 to 10 mg, and tablets come in 0.5 mg, 1 mg and 2 mg. The label also says Ativan’s effectiveness beyond 4 months has not been assessed in systematic studies.

How an Ativan taper works

Do not stop Ativan on your own after regular use; the label, the Medication Guide and the 2025 guideline all say the same thing. What the joint guideline recommends instead, for clinicians planning a taper with a patient:

• Pace. The guideline tells clinicians to start with dose cuts of 5 to 10 percent every 2 to 4 weeks, and typically not faster than 25 percent every 2 weeks. The prescriber sets each step.
• Short courses can move faster. For someone on a lower dose for a relatively short time, for example under 3 months, the guideline lets clinicians consider the higher end, 10 to 25 percent.
• Pause before pushing. If significant symptoms appear, the guideline says the taper should be slowed or paused, and the Ativan label says the prescriber can consider going back to the previous dose and then tapering more slowly. Report symptoms to the prescriber instead of changing the dose yourself.
• Switching drugs is a judgment call. The guideline says clinicians can consider moving a patient to a comparable dose of a longer-acting benzodiazepine for the taper, but that guidelines disagree, and the decision should weigh liver function and other medicines. For people with significant liver disease, it calls lorazepam itself the better agent.
• Therapy helps. The guideline recommends offering cognitive behavioral therapy or CBT for insomnia during a taper, citing a Cochrane review that found people who got CBT were more likely to have stopped at 1 and 3 months.
• Check in at every step. The guideline asks clinicians to evaluate the patient for withdrawal symptoms with each dose reduction.

On speed, the guideline points to its own evidence: clinical trials that cut doses faster tended to have high dropout rates. It also tells clinicians to avoid flumazenil, a benzodiazepine reversal drug, as part of a taper, because of the risk of seizures that do not respond to treatment and heart rhythm problems.

Ativan withdrawal seizures

Seizures are the reason this is not a wait-it-out withdrawal. The label lists seizures among the life-threatening reactions to abrupt discontinuation or rapid dose reduction, and the Medication Guide tells patients to call their provider or go to the nearest emergency room right away if they appear. The guideline marks seizures, delirium and psychosis as typically associated with abrupt stops of high doses, and says a past seizure raises the risk of a withdrawal seizure, as do other medicines that lower the seizure threshold.

If someone has had a withdrawal seizure before, tell every clinician involved. The guideline notes that addiction medicine specialists commonly add an anticonvulsant for people with that history, that neurologists generally do not, and that its panel did not reach consensus on it.

When Ativan withdrawal needs inpatient care

Most people can taper in an outpatient setting, according to the guideline. It says clinicians should consider inpatient or medically managed residential care when:

• Severe or complicated withdrawal is happening or expected, including a history of withdrawal seizures or delirium.
• Continued use poses an imminent risk, such as recent falls, car crashes, overdose, or suicidality, that the first dose reduction will not fix fast enough.
• Another serious condition, such as a poorly controlled seizure disorder, cannot be managed safely as an outpatient.

In those settings, the guideline calls for regular vital signs, a structured withdrawal scale, and seizure-risk assessment. Tapers with very long-acting drugs such as phenobarbital belong only in inpatient care, run by or with clinicians experienced in them. A taper can start inpatient and finish outpatient. Our guide to what happens during detox explains the inpatient part, and benzodiazepine detox in New Jersey covers where it happens.

Ativan with alcohol, opioids, or pills from the street

The label’s boxed warning starts with opioids: Ativan taken with opioids can cause profound sedation, slowed breathing, coma and death. The label also says alcohol and other central nervous system depressants add to lorazepam’s effects. Someone withdrawing from alcohol and Ativan at once has two withdrawals that can both cause seizures, which is a supervised-detox situation; see can you detox from alcohol at home.

For someone on methadone or buprenorphine, ASAM says benzodiazepine use should not be a reason to withhold or suspend opioid treatment, and the 2025 guideline says the opioid medication dose should stay stable through the benzodiazepine taper.

Pills sold as Ativan outside a pharmacy are a different risk. The guideline warns that counterfeit benzodiazepines can contain novel synthetic benzodiazepines that standard drug tests may miss, and can contain fentanyl, so a person may be at risk of opioid withdrawal and overdose without knowing it. The DEA’s One Pill Can Kill campaign makes the same point. Tell the detox team exactly where the pills came from.

Ativan withdrawal in pregnancy and in older adults

Pregnancy. The label warns that lorazepam late in pregnancy can cause sedation and withdrawal symptoms in the newborn. The guideline asks clinicians to weigh tapering against staying on the medicine with the pregnant patient, and calls lorazepam generally preferred in pregnancy and breastfeeding. Neither source supports stopping suddenly. Our detox while pregnant guide covers the rest.

Older adults. The label says elderly patients may be more sensitive to lorazepam’s sedation and recommends a lower starting dose. Our page on detox for older adults covers falls, delirium and the Beers Criteria.

Can you taper off Ativan at home?

Usually, yes, with a prescriber running the taper. When the 2025 guideline says most people can taper as outpatients, it means a prescriber-led taper: you take the doses at home as scheduled, report symptoms, and the pace adjusts. What does not belong at home is the unplanned version: stopping cold, cutting the dose sharply on your own, stretching a supply with pills from someone else, or trying to come off Ativan and alcohol at the same time. A history of seizures or delirium, pregnancy, opioid use, or heavy drinking moves the answer toward supervised care. If you take Xanax as well or instead, our Xanax withdrawal guide covers whether you can taper off Xanax at home.

Questions to ask before a taper starts

1. Given how long and how much I have taken, how likely is withdrawal, and how fast should we go?
2. Should I stay on lorazepam for the taper or switch to a longer-acting drug, and why?
3. If a step goes badly, can we pause or go back to the last dose?
4. I have had a seizure before, or I drink or use opioids. Does that change where this should happen?

In New Jersey

Under New Jersey law P.L.2017, c.28, fully insured New Jersey plans and the State Health Benefits and School Employees’ plans cannot require prior authorization for the first 180 days per plan year of in-network treatment your own physician, psychologist or psychiatrist finds medically necessary, or, during those same 180 days, for outpatient prescription drugs that treat substance use disorder, such as buprenorphine and naltrexone, when that clinician finds them medically necessary. Self-funded employer plans, Medicare and Medicaid are not covered by that rule, so verify with the plan.

For help independent of us, the state’s IME Addictions Access Center at 1-844-276-2777 screens NJ FamilyCare and uninsured residents and refers them to treatment, and ReachNJ, the state treatment line, is at 1-844-732-2465. Periscope Behavioral Health, which publishes this site, is opening a medical detox in Hammonton, Atlantic County, expected Summer 2027. Until it opens, Periscope Behavioral Health at (888) 313-3583, our publisher’s admissions line, can talk through options in New Jersey and Florida, including facilities Periscope operates. What a plan covers depends on the plan and the facility’s network status.

Keep taking lorazepam as prescribed while you make those calls. A program can plan a taper around the dose you are on; it cannot undo a seizure.